SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Bought by HB Wealth Management LLC

HB Wealth Management LLC boosted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,280 shares of the exchange traded fund’s stock after buying an additional 200 shares during the period. HB Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $382,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. boosted its stake in SPDR S&P Biotech ETF by 179.1% during the first quarter. JPMorgan Chase & Co. now owns 7,534,471 shares of the exchange traded fund’s stock worth $574,202,000 after buying an additional 4,835,071 shares during the last quarter. Phoenix Holdings Ltd. lifted its stake in shares of SPDR S&P Biotech ETF by 0.8% in the 3rd quarter. Phoenix Holdings Ltd. now owns 2,151,359 shares of the exchange traded fund’s stock valued at $157,092,000 after purchasing an additional 17,221 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of SPDR S&P Biotech ETF by 103.3% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,771,000 shares of the exchange traded fund’s stock valued at $129,318,000 after purchasing an additional 900,000 shares during the last quarter. Jane Street Group LLC lifted its stake in shares of SPDR S&P Biotech ETF by 315.1% in the 1st quarter. Jane Street Group LLC now owns 1,529,813 shares of the exchange traded fund’s stock valued at $116,587,000 after purchasing an additional 1,161,234 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at $102,900,000.

SPDR S&P Biotech ETF Stock Up 2.4 %

Shares of SPDR S&P Biotech ETF stock opened at $94.91 on Thursday. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The business’s fifty day simple moving average is $93.27 and its 200-day simple moving average is $82.57. The firm has a market cap of $7.28 billion, a PE ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.